Meningococcus B, multicomponent vaccine

1 Drug classified under this active ingredient

Meningococcal Vaccine. Meningococcus B, multicomponent vaccine (subfamily A1,2,3) 60 mcg, Meningococcus B, multicomponent vaccine (subfamily B1,2,3) 60 mcg.
VIAL (susp. for IM inj.): 1,5,10 × 0.5ml.
Primary series: 2 doses (0.5 ml each) admin. at a 6 mnth. interval.
3 doses: 2 doses (0.5 ml each) adm. at least 1 mnth. apart, followed by a 3^rd dose at least 4 mnths. after the 2^nd dose.
Booster dose: A booster dose should be consid. follow. either dosing regimen for individuals at continued risk of invas. meningococcal dis.
Other ped. population: not indicated for child. under 10 yrs. old.
Active immunisation of individ. 10 yrs. and older to prevent invas. meningococ. dis. caused by Neisseria meningitidis serogroup B.
The use of this vaccine should be in accordance with official recommendations.
C/I: Hypersens.